Bactericidal activity of nukacin ISK-1: An alternative mode of action

Bioscience, Biotechnology and Biochemistry

Volumn 78, Issue 7, 2014, Pages 1270-1273

  Roy, Urmi ^a   Islam, Mohammad Riazul ^a   Nagao, Jun Ichi ^b   Iida, Hiroshi ^a   Mahin, Abdullah Al ^a   Li, Mengqi ^a   Zendo, Takeshi ^a   Nakayama, Jiro ^a   Sonomoto, Kenji ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA DENTAL COLLEGE   (Japan)

Author keywords

Antimicrobial peptide; Bactericidal activity; Lantibiotic; Mode of action; Unusual amino acid

Indexed keywords

BACTERIOLOGY;

ANTIMICROBIAL PEPTIDE; BACILLUS SUBTILIS; BACTERICIDAL ACTIVITY; BACTERIOSTATIC ACTIONS; LANTIBIOTICS; MEMBRANE POTENTIALS; MICROCOCCUS LUTEUS; MODE OF ACTION;

BACTERICIDES;

BACILLUS SUBTILIS; MICROCOCCUS LUTEUS; STAPHYLOCOCCUS SIMULANS;

ANTIINFECTIVE AGENT; BACTERIOCIN; NUKACIN ISK-1;

BACTERIUM; DRUG EFFECTS; ISOLATION AND PURIFICATION;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIOCINS;

EID: 84930714307     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1080/09168451.2014.918485     Document Type: Article

References (17)

1. Cotter PD, Ross RP, Hill C. Bacteriocins- a viable alternative to antibiotics? Nat. Rev. Microbiol. 2013;11:95-105.
2. Delves-Broughton J, Blackburn P, Evans RJ, Hugenholtz J. Applications of the bacteriocin, nisin. Antonie van Leeuwenhoek. 1996;69:193-202.
3. Joo NE, Ritchie K, Kamarajan P, Miao D, Kapila YL. Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC1. Cancer Med. 2012;1:295-305.
4. Jung G. Lantibiotics: a survey. In: Jung G, Sahl H-G, editors. Nisin and novel lantibiotics. Leiden: ESCOM; 1991. p. 1-34.
5. Willey JM, van der Donk WA. Lantibiotics: peptides of diverse structure and function. Annu. Rev. Microbiol. 2007;61:477-501.
6. Wiedemann I, Benz R, Sahl H-G. Lipid II-mediated pore formation by the peptide antibiotic nisin: a black lipid membrane study. J. Bacteriol. 2004;186:3259-3261.
7. Arnison PG, Bibb MJ, Bierbaum G, Bowers AA, Bugni TS, Bulaj G, Camarero JA, Campopiano DJ, Challis GL, Clardy J, Cotter PD, Craik DJ, Dawson M, Dittmann E, Donadio S, Dorrestein PC, Entian KD, Fischbach MA, Garavelli JS, Göransson U, Gruber CW, Haft DH, Hemscheidt TK, Hertweck C, Hill C, Horswill AR, Jaspars M, Kelly WL, Klinman JP, Kuipers OP, Link AJ, Liu W, Marahiel MA, Mitchell DA, Moll GN, Moore BS, Müller R, Nair SK, Nes IF, Norris GE, Olivera BM, Onaka H, Patchett ML, Piel J, Reaney MJ, Rebuffat S, Ross RP, Sahl HG, Schmidt EW, Selsted ME, Severinov K, Shen B, Sivonen K, Smith L, Stein T, Süssmuth RD, Tagg JR, Tang GL, Truman AW, Vederas JC, Walsh CT, Walton JD, Wenzel SC, Willey JM, van der Donk WA. Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat. Prod. Rep. 2013;30:108-160.
8. Islam MR, Nishie M, Nagao J, Zendo T, Keller S, Nakayama J, Kohda D, Sahl H-G, Sonomoto K. Ring A of nukacin ISK-1: a lipid II-binding motif for type-A(II) lantibiotic. J. Am. Chem. Soc. 2012;134:3687-3690.
9. Asaduzzaman SM, Nagao J, Iida H, Zendo T, Nakayama J, Sonomoto K. Nukacin ISK-1, a bacteriostatic lantibiotic. Antimicrob. Agents Chemother. 2009;53:3595-3598.
10. Aso Y, Okuda K, Nagao J, Kamenasa Y, Phuong NTB, Koga H, Shioya K, Sashihara T, Nakayama J, Sonomoto K. A novel type of immunity protein, NukH, for the lantibiotic nukacin ISK-1 produced by Staphylococcus warneri ISK-1. Biosci. Biotechnol. Biochem. 2005;69:1403-1410.
11. Bonelli RR, Schneider T, Sahl H-G, Wiedemann I. Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies. Antimicrob. Agents Chemother. 2006;50:1449-1457.
12. Silverman JA, Perlmutter NG, Shapiro HM. Correction of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob. Agents Chemother. 2003;47:2538-2544.
13. Jack R, Benz R, Tagg J, Sahl H-G. The mode of action of SA-FF22, a lantibiotic isolated from Streptococcus pyogenes strain FF22. Eur. J. Biochem. 1994;219:699-705.
14. Herranz C, Cintas LM, Hernandez PE, Moll GN, Driessen AJM. Enterocin P causes potassium ion efflux from Enterococcus faecium T136 cells. Antimicrob. Agents Chemother. 2001;45:901-904.
15. Mantovani HC, Russel JB. Bovicin HC5, a lantibiotic produced by Streptococcus bovis HC5, catalyzes the efflux of intracellular potassium but not ATP. Antimicrob. Agents Chemother. 2008;52:2247-2249.
16. Iida H, Wang L, Nishii K, Ookuma A, Shibata Y. Identification of rab12 as a secretory granule-associated small GTP-binding protein in atrial myocytes. Circ. Res. 1996;78:343-347.
17. Christ K, Al-Kaddah S, Wiedemann I, Rattay B, Sahl H-G, Bendas G. Membrance lipids determine the antibiotic activity of the lantibiotic gallidermin. J. Membr. Biol. 2008;226:9-16.